Mizuho initiated coverage on Tandem Diabetes Care with a new price target

4/10/25 12:43:51 PM ET

$TNDM

Medical/Dental Instruments

Health Care

Get the next $TNDM alert in real time by email

Mizuho initiated coverage of Tandem Diabetes Care with a rating of Neutral and set a new price target of $20.00

Get the next $TNDM alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TNDM

Date	Price Target	Rating	Analyst
6/16/2025	$24.00	Hold	Truist
4/10/2025	$20.00	Neutral	Mizuho
3/5/2025	$45.00 → $22.00	Overweight → Equal-Weight	Morgan Stanley
3/4/2025	$35.00 → $24.00	Buy → Neutral	Citigroup
3/3/2025	$38.00 → $22.00	Overweight → Equal Weight	Wells Fargo
2/28/2025	$35.00 → $25.00	Outperform → Mkt Perform	Bernstein
12/2/2024	$45.00	Equal-Weight → Overweight	Morgan Stanley
11/6/2024	$42.00	Outperform	Bernstein

More analyst ratings

Mizuho initiated coverage on Tandem Diabetes Care with a new price target

Chat with this insight

Recent Analyst Ratings for
$TNDM

$TNDM
SEC Filings

SEC Form SD filed by Tandem Diabetes Care Inc.

Tandem Diabetes Care Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

Tandem Diabetes Care Inc. filed SEC Form 8-K: Other Events

$TNDM
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

EVP & Chief Operating Officer Kyrillos Jean-Claude bought $190,966 worth of shares (10,538 units at $18.12) (SEC Form 4)

EVP & CHIEF COMMERCIAL OFFICER Novara Mark David bought $12,364 worth of shares (532 units at $23.24) (SEC Form 4)

Allen Dick bought $94,778 worth of shares (5,000 units at $18.96), increasing direct ownership by 33% to 19,962 units (SEC Form 4)

$TNDM
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Technology Officer Carpenter Rick converted options into 406 shares and covered exercise/tax liability with 207 shares, increasing direct ownership by 0.95% to 21,219 units (SEC Form 4)

EVP & CHIEF COMMERCIAL OFFICER Novara Mark David converted options into 7,414 shares and covered exercise/tax liability with 3,846 shares, increasing direct ownership by 14% to 28,763 units (SEC Form 4)

Director Cha Myoungil converted options into 1,749 shares, increasing direct ownership by 15% to 13,699 units (SEC Form 4)

Mizuho initiated coverage on Tandem Diabetes Care with a new price target

Chat with this insight

Recent Analyst Ratings for $TNDM

$TNDM SEC Filings

SEC Form SD filed by Tandem Diabetes Care Inc.

Tandem Diabetes Care Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

Tandem Diabetes Care Inc. filed SEC Form 8-K: Other Events

$TNDM Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

EVP & Chief Operating Officer Kyrillos Jean-Claude bought $190,966 worth of shares (10,538 units at $18.12) (SEC Form 4)

EVP & CHIEF COMMERCIAL OFFICER Novara Mark David bought $12,364 worth of shares (532 units at $23.24) (SEC Form 4)

Allen Dick bought $94,778 worth of shares (5,000 units at $18.96), increasing direct ownership by 33% to 19,962 units (SEC Form 4)

$TNDM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Technology Officer Carpenter Rick converted options into 406 shares and covered exercise/tax liability with 207 shares, increasing direct ownership by 0.95% to 21,219 units (SEC Form 4)

EVP & CHIEF COMMERCIAL OFFICER Novara Mark David converted options into 7,414 shares and covered exercise/tax liability with 3,846 shares, increasing direct ownership by 14% to 28,763 units (SEC Form 4)

Director Cha Myoungil converted options into 1,749 shares, increasing direct ownership by 15% to 13,699 units (SEC Form 4)

Recent Analyst Ratings for
$TNDM

$TNDM
SEC Filings

$TNDM
Insider Purchases

$TNDM
Insider Trading